Joseph H Capper has bought stock on 4 days since Jun 2023
Director at TELA Bio, Inc., and 1 other company
SEC CIK 0001456817 · Filings on SEC.gov ↗
Joseph H Capper's record
3 months after each buy, from the first price a copier could get.
2 buys have 3 months of prices so far. A record shows here at 3.
Companies
Every filing
4 filings since Jun 2023, newest first
About Joseph H Capper
Joseph H. Capper (age 61) is the Chief Executive Officer and a Director of MiMedx Group, Inc. (MDXG), a position he has held since January 2023.( He brings nearly 30 years of experience in MedTech and life sciences leadership, including prior CEO roles at BioTelemetry, Inc. (2010–2021), where he led a turnaround culminating in its $2.8 billion acquisition by Royal Philips; President and CEO of Home Diagnostics and CCS Medical; and commercial leadership roles at Bayer AG.( Earlier in his career, he served as a U.S. Navy naval aviator.(
Capper holds a B.S. in Accounting from West Chester University and an MBA in International Finance from George Washington University.( Under his leadership at MiMedx, the company achieved 2024 net sales of $348.879 million (up 9% YoY), Adjusted EBITDA of $76.440 million, and strategic advancements including the launch of HELIOGEN xenograft and MIMEDX Connect portal.( He was named Healthcare CEO of the Year in 2019 by the Philadelphia Alliance for Capital and Technologies for his BioTelemetry work.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.